Laura K. Aguilar
CIK 1873915 · Chief Medical Officer · last filed 2025-02-13
Laura K. Aguilar is a Chief Medical Officer who has filed 7 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing shows the insider disposed of $539.6K of CADL on Feb 13, 2025. Across all open-market trades the lifetime net is −$487.7K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.64M
1
7
-$487.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CADL | 10%+ Owner | 191,443 | $8.56 | $1.64M | -$487.7K | 7 | 2025-02-13 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-13 | CADL | Disp (D) | −62,670 | -$539.6K | EDGAR |
| 2024-12-30 | CADL | Disp (D) | −400,000 | -$3.57M | EDGAR |
| 2024-12-13 | CADL | Disp (D) | −1,600,000 | -$14.86M | EDGAR |
| 2024-10-28 | CADL | Disp (D) | −61,858 | -$344.6K | EDGAR |
| 2024-10-15 | CADL | Sell (S) | −80,824 | -$487.7K | EDGAR |
| 2022-05-10 | CADL | Mixed | +102,801 | $0 | EDGAR |
| 2021-08-02 | CADL | Conv (C) | +56,096 | $0 | EDGAR |